Clin Infect Dis
- DENYER RV, Tate JP, Benator DA, Lim JK, et al
Hepatitis B Reactivation in a US Cohort of People With Human Immunodeficiency
Virus and Hepatitis B Core Antibody After Switch to Antiretroviral Therapy
Without Hepatitis B Activity.
Clin Infect Dis. 2026 Feb 24:ciag001. doi: 10.1093.
Gastroenterol Hepatol
- LENS S, Garcia F, Mascort J, Casado M, et al
Consensus document on the diagnosis, management, and treatment of chronic
hepatitis B virus and hepatitis D virus infection in Spain.
Gastroenterol Hepatol. 2026 Mar 11:502717. doi: 10.1016/j.gastrohep.2026.502717.
Hepatology
- TORNAI D, Mitchell MC, McClain CJ, Dasarathy S, et al
Longitudinal assessment of circulating cytokine profile of severe
alcohol-associated hepatitis.
Hepatology. 2026 Mar 13. doi: 10.1097/HEP.0000000000001743.
- PUTIGNANO A, Kelkar NS, Lakhloufi D, Sharma S, et al
Antibody response to microbiota antigens is associated with alcohol-related liver
disease severity and predicts mortality.
Hepatology. 2026;83:838-850.
J Hepatol
- SONNEVELD MJ, Janssen HLA
Is Partial Cure a Realistic Endpoint for Novel Hepatitis B Therapy? Reply to Chan
et al.
J Hepatol. 2026 Mar 11:S0168-8278(26)00134-0. doi: 10.1016/j.jhep.2026.
- SONNEVELD MJ, Janssen HLA
Individualising endpoints in chronic HBV treatment: HBsAg loss and beyond.
J Hepatol. 2026;84:823-828.
J Infect Dis
- MANI M, Clipman SJ, Bailey JR, Sterling RK, et al
Single-cell hepatitis B sequencing reveals distinct viral infection events
consistent with superinfection.
J Infect Dis. 2026 Mar 20:jiag181. doi: 10.1093.
J Med Virol
- PAMARTHI J, Panneerselvam S, Rajesh NA, Kumar JS, et al
Pregenomic RNA as a Marker for Monitoring Disease Prognosis and Viral Relapse in
Hepatitis B Patients on Long-Term Antiviral Therapy: A Systematic Review and
Meta-Analysis.
J Med Virol. 2026;98:e70866.
- ZHANG X, Han J, Hu Q, Zhang Y, et al
3D Radiomics Analysis Based on Liver CT Imaging for Predicting Hepatic
Encephalopathy in HBV-ACLF Patients.
J Med Virol. 2026;98:e70871.
- SHIUE SJ, Ho TH, Lin HY, Cheng SW, et al
Impact of Metabolic Associated Steatotic Liver Disease on Antiviral Therapy
Outcomes on Chronic Hepatitis B Patients Receiving Antiviral Therapy.
J Med Virol. 2026;98:e70864.
J Viral Hepat
- WANG DH, Wang JL, Jiang SW, Zhou AW, et al
HBV RNA Predicts the Risk of Off-Treatment Relapse in Chronic Hepatitis B
Patients With NAs Therapy: A Systematic Review and Meta-Analysis.
J Viral Hepat. 2026;33:e70167.
- CAVIGLIA GP, Stroffolini T
Changing Pattern of HDV Infection in Italy Over 40 Years; the Current Scenario
and the Impending Challenge.
J Viral Hepat. 2026;33:e70172.
- HARRISON R, Patel S, Marra F, Francisco A, et al
Co-Administration of Hepatitis C Direct-Acting Antivirals and Enzyme-Inducing
Antiepileptic Drugs: Real-World Experience From a Multi-Centre Case Series.
J Viral Hepat. 2026;33:e70168.
- THAKUR HS, Yadav V
Methodological Considerations in Prevalence Meta-Analysis of Hepatitis B Among
Migrants.
J Viral Hepat. 2026;33:e70171.
- THOMPSON K, Thompson J, Miller LS
Characteristics of Patients and Factors Associated With the Development of
Hepatitis C Virus-Associated Hepatocellular Carcinoma in an Urban, Primary-Care
Based Hepatitis C Clinic.
J Viral Hepat. 2026;33:e70169.
- GUO L, Wu W, Zhou W, Liang R, et al
Exploration of a Model for Elimination of Hepatitis C in Women of Childbearing
Age in Primary Hospitals in Southern China.
J Viral Hepat. 2026;33:e70153.
Minerva Gastroenterol (Torino)
- KARABAY O, Kabukcu S, Guclu E, Zerdali E, et al
Investigation of the effects of antivirals used in hepatitis B treatment on blood
lipid profile: a retrospective real-life data analysis.
Minerva Gastroenterol (Torino). 2026 Mar 18. doi: 10.23736/S2724-5985.26.03992.
- BATTISTELLA S, LE Piane F, Galante A, Coppola C, et al
Evaluation of Italian clinical practice for preventing HBV recurrence post-LT: a
Delphi panel study.
Minerva Gastroenterol (Torino). 2026;72:25-36.
PLoS One
-
Expression of Concern: Seroepidemiology and associated risk factors of hepatitis
B and C virus infections among pregnant women attending maternity wards at two
hospitals in Swabi, Khyber Pakhtunkhwa, Pakistan.
PLoS One. 2026;21:e0345147.
- KELLY SE, Ajidahun A, Bytelaar S, Ding E, et al
Beyond direct-acting antiviral therapy: Characterizing mental health conditions
and depressive symptoms among patients recently treated for hepatitis C.
PLoS One. 2026;21:e0344862.
PLoS Pathog
- ZHANG H, Wu Y, Wang H, Liu T, et al
Experimental hepatitis E virus genotype 1 infection in three types of wild
rodents.
PLoS Pathog. 2026;22:e1014050.
Vaccine
- LOEHR J, Moser CA, Asturias EJ, Shaw AC, et al
Science for vaccine policy: Lack of transparency, misinformation, and poor
decision processes at the December 2025 ACIP meeting.
Vaccine. 2026;76:128338.
- TROCCOLI CS, Nascimento PS, Villar LM, Miguel JC, et al
Long-term persistence of Seroprotection following a modified hepatitis B vaccine
schedule in people living with HIV.
Vaccine. 2026;79:128483.
Virology
- VITIELLO A, Boccellino M, Polito G, Zovi A, et al
Hepatitis D Infection: a puzzle still unsolved?
Virology. 2026;619:110879.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016